The HealthPod

Episodes

1. 16

   Its an MDMA kind of day

   This episode we revisit another psychedilic MDMA. Its crazy how there are people that abhorrently deny the benefit of these "recreational" drugs. I am giving some brief data on how MDMA can prove useful.' MAPS clinical trial- http://bit.ly/2FNZP78 Current Perspective on MDMA-Assisted…

   more
   Apr 1, 2019

   15m
2. 15

   Stop at your doctor's before your next Rave

   Move over anti-depressents there's a new MOA in town. This episode details a new intranasal ketamine produce by Janssen pharmaceuticals. This is a brief look at the data we have so far. Enjoy! SPRAVATO- http://bit.ly/2URxZfv Pharmacology of Ketamine study- http://bit.ly/2HyzETT

   Mar 20, 2019

   14m
3. 14

   Morning drugs

   This episode delves into a drug that most of us need on a daily basis. CAFFEINE. This wonder molecule affects so many of our body's processes. If your curious how it works and what makes it affect you so profoundly, give this episode a listen. Enjoy! Genetics of caffeine consumption and responses...

   Mar 7, 2019

   24m
4. 13

   Statins under 30 part 2

   This episode revisits why statins and if they are as beneficial as currently believed. There are many nuances about statins and confusion. Hopefully this episode clears things up! Saturated fat is not the major issue -http://bit.ly/2GxkgH9 Low-Density Lipoprotein Cholesterol Lowering for the...

   Feb 19, 2019

   36m
5. 12

   President Trump's State of the Union address

   This episode is going to go over what I found related the most to in the state of the union address to healthcare. There were many outlandish claims but this address could have been way worse than it turned out. https://wb.md/2GtrTgR

   Feb 7, 2019

   6m
6. 11

   Flu upswing and a new Advair generic

   This episode is a brief synopsis on trends in the Flu season so far and a new FDA generic approval of a long standing respiratory inhaler. Influenza upswing- https://wb.md/2UJFnJm Advair generic- https://wb.md/2TyoD7r

   Feb 6, 2019

   7m
7. 10

   Recalls on Recalls!

   FDA statement on ARBs recalls- http://bit.ly/2DVNxZA Ibuprofen Recall by Tris Pharm Inc.- http://bit.ly/2RKKzLa The various lots recalled include: Lot 4718 — sold in a .5 oz. bottle with an expiration date of Dec. 2019 — and lot 00717006A — sold in a 1 oz. bottle with an expiration date of Feb....

   Feb 5, 2019

   7m
8. 9

   What's new with the opioid epidemic?

   This episode is a brief update on the opioid epidemic. A Perspective Regarding the Current State of the Opioid Epidemic. | Psychiatry | JAMA Network Open | JAMA Network- http://bit.ly/2WEZaLw FDA announcemet- http://bit.ly/2DQh8TW

   Feb 4, 2019

   11m
9. 8

   N.Y.C universal health care and Mega infection

   This episode is the introduction into my new format of shorter and more digestible episodes. N.Y.C healthcare- https://wb.md/2UzRA Wyoming patient infected- https://wb.md/2GhTaTw

   Feb 1, 2019

   7m
10. 7

    Clot permeability and Xarelto, Flu data, ARB recalls, Celgene aquisition

    1. Clot permeability and Thrombolytic risk: https://wb.md/2CVGv6t What is clot permeability: http://bit.ly/2CVFD1H 2. Andexxa Commercial Production Approval: https://wb.md/2CThfOe 3. Flu data: https://wb.md/2Vx0Q9s CDC Reports: http://bit.ly/2CVaTO8 4. Sartan Saga: https://wb.md/2FfgukM…

    more
    Jan 7, 2019

    19m
11. 6

    Flu updates and high risks

    What better way to start the year then with staying on top of healthcare. This episode covers the new flu guidelines, a novel mechanism in schizophrenia, and Newly found risk of basal insulin and sulfonylureas. IDSA influenza guidelines- http://bit.ly/2QYLM5Q Novel schizophrenia molecule…

    more
    Dec 31, 2018

    23m
12. 5

    Valsartan recall update, VTE risk reduction, and Novel therapies

    This week I review what's going on with the Valsartan recall, VTE risk reduction in prophylaxis, Increased death in children with antipsychotics, new cannabis therapy, and new use for modafinil. 1. Valsartan recall https://wb.md/2EBred0 FDA warning letter: http://bit.ly/2STOdTF 2. Apixiban...

    Dec 18, 2018

    30m
13. 4

    More Valsartan recalls! Drug approvals, and Cholesterol medications

    This episode reviews what has happened in the previous week in healthcare. For more information on the topics discussed please see the links provided. Valsartan recall: https://www.medscape.com/viewarticle/906158 FDA list of recent Mylan lots:...

    Dec 12, 2018

    20m
14. 3

    Statins under 30 part 1

    Ever wonder why take a statin? Especially if your young and beautiful other health problems. Take a listen to this podcast and learn why.

    Dec 8, 2018

    9m
15. 2

    Valsartan recalls, new guidelines, and cancer drugs

    This episode goes into some more valsartan recalls, AML drugs and AHA HTN guidelines controversy, and lipid guidelines

    Dec 3, 2018

    23m
16. 1

    Week 11/28/18

    1. Valsartan recall 2. Travelers diarrhea 3. AML 4. Supplement contamination 5. Chicago shooting

    Nov 26, 2018

    17m